Skip to main content

Peer Review reports

From: Serum miRNA-1 may serve as a promising noninvasive biomarker for predicting treatment response in breast cancer patients receiving neoadjuvant chemotherapy

Original Submission
6 Mar 2024 Submitted Original manuscript
13 Mar 2024 Author responded Author comments - Liheng Zhou
15 Apr 2024 Reviewed Reviewer Report - Yunda Zhang
29 Apr 2024 Reviewed Reviewer Report - Tongbo Yi
8 May 2024 Author responded Author comments - Liheng Zhou
Resubmission - Version 2
13 Mar 2024 Submitted Manuscript version 2
9 May 2024 Author responded Author comments - Liheng Zhou
Resubmission - Version 3
9 May 2024 Submitted Manuscript version 3
10 May 2024 Author responded Author comments - Liheng Zhou
Resubmission - Version 4
10 May 2024 Submitted Manuscript version 4
23 May 2024 Reviewed Reviewer Report - Tongbo Yi
Resubmission - Version 5
Submitted Manuscript version 5
Publishing
10 Jun 2024 Editorially accepted
2 Jul 2024 Article published 10.1186/s12885-024-12500-6

You can find further information about peer review here.

Back to article page